Hollenbeck M, Niehuus A, Wozniak G, Hennigs S
Innere Medizin II - Nephrologie, Rheumatologie, Intensivmedizin, Knappschaftskrankenhaus Bottrop, Osterfelderstr. 155a, 46242 Bottrop, Germany.
Chirurg. 2012 Sep;83(9):801-8. doi: 10.1007/s00104-012-2306-x.
Central venous dialysis catheters are indispensible as a rapid large lumen access to the blood compartment. If such a central venous catheter is necessary for longer than 2-3 weeks it is better to implant a tunnelled cuffed catheter initially or to switch early from the non-tunnelled acute catheter to a tunnelled cuffed catheter. Tunnelled cuffed catheters can be used for many weeks or even years and the complication rate is less than that of non-tunnelled acute catheters. The proportion of dialysis patients with long-term dialysis using tunnelled cuffed catheters has increased rapidly in recent years and now stands at approximately 20 % in Germany. These catheters are, however, prone to more infectious complications and more thromboses than native arteriovenous fistulas or prosthetic shunts. The mortality of patients with long-term dialysis catheters is also higher than those with arteriovenous shunts. For these reasons central venous catheters will always be regarded as the third choice dialysis access when arteriovenous fistulas are not possible. Catheters are available in a wide variety of designs but the individual advantages are still unclear. In order to avoid short-term and long-term complications a variety of measures for implantation and use during dialysis treatment have been developed which make the use safer.
中心静脉透析导管作为一种快速、大腔径的进入血循环的通路是必不可少的。如果需要使用这种中心静脉导管超过2 - 3周,最好最初就植入带隧道带涤纶套的导管,或者尽早从非隧道式急性导管转换为带隧道带涤纶套的导管。带隧道带涤纶套的导管可使用数周甚至数年,其并发症发生率低于非隧道式急性导管。近年来,使用带隧道带涤纶套导管进行长期透析的透析患者比例迅速增加,在德国目前约为20%。然而,与自体动静脉内瘘或人工血管分流相比,这些导管更容易发生感染性并发症和血栓形成。长期使用透析导管的患者死亡率也高于动静脉分流患者。由于这些原因,当无法建立动静脉内瘘时,中心静脉导管将一直被视为透析通路的第三选择。导管有多种设计,但各自的优势仍不明确。为了避免短期和长期并发症,已经开发了多种在透析治疗期间植入和使用导管的措施,从而使导管使用更安全。